A phase 2 trial suggests that the novel SNRI ammoxetine may effectively treat major depressive disorder while avoiding some side effects common to other antidepressants.

A new study has found that psychotherapy can lead to observable changes in the physical structure of the brain for people ...

Compared with sham therapy, 12 days of personalized treatment with high-definition transcranial direct current stimulation ...

A new study involving the German Center for Diabetes Research (DZD) provides strong evidence that sugary drinks affect not ...

Research on rare post-mortem brain tissue shows changes in gene activity, offering new insight into the biological basis of ...

(HealthDay News) — Psilocybin-assisted therapy (PAT) shows long-term safety and efficacy for treating symptoms of major depressive disorder (MDD), according to a study published online Sept. 4 in the ...

Skoltech scientists and their colleagues from other Russian medical research centers and mental health institutions have ...

Imagine wading through severe depression for years, taking medication after medication, with no relief. Now, envision discovering that what you were facing was not major depression but bipolar ...

A new study involving the German Center fo Research (DZD) provides strong evidence that sugary drinks affect not only ...

Large Swedish cohort study finds delusional disorder, acute psychoses, psychosis NOS, and schizoaffective disorder are genetically distinct from SZ, BD, and MD.

Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...

As daylight diminishes people can feel their mood dimming. In fact millions of U.S. adults experience seasonal affective ...